Liposome longevity and stability in circulation : Effects of the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclinesGABIZON, A; CHEMLA, M; TZEMACH, D et al.Journal of drug targeting. 1996, Vol 3, Num 5, pp 391-398, issn 1061-186XArticle

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (doxil) in metastatic breast carcinomaLYASS, O; UZIELY, B; BEN-YOSEF, R et al.Cancer. 2000, Vol 89, Num 5, pp 1037-1047, issn 0008-543XArticle

Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomesSYMON, Z; PEYSER, A; TZEMACH, D et al.Cancer. 1999, Vol 86, Num 1, pp 72-78, issn 0008-543XArticle